Relmada Therapeutics, Inc.(RLMD) News

Date	Title
Oct 6	Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs at the 36th European College of Neuropsychopharmacology (ECNP) Congress
Aug 8	Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results